SR

Sowjanya Reddy Evuri

Active Director Director DIN 08582622
DIN 08582622 First appointment Oct 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Sowjanya Reddy Evuri

Data last updated:

Sowjanya Reddy Evuri is a Director at Neuberg Life Sciences Private Limited (since 2019). The company operates in Healthcare. Neuberg Life Sciences Private Limited reported revenue of ₹14.1 Lakh (FY 2022).

DIN 08582622
Primary Designation Director
Industry Healthcare
First Appointment 09 Oct 2019
Oldest Company Age 7 yrs
Largest company Neuberg Life Sciences Private Limited · ₹14.1 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Oct 20192019₹14.1 Lakh (FY 2022)Active

Board colleagues of Sowjanya Reddy Evuri

Directorship timeline

Open interactive timeline →
Neuberg Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sowjanya Reddy Evuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sowjanya Reddy Evuri

Sowjanya Reddy Evuri currently holds 1 directorship: Neuberg Life Sciences Private Limited (Director, since 09 Oct 2019, revenue ₹14.1 Lakh (FY 2022)).

Sowjanya Reddy Evuri was first appointed on 09 Oct 2019 as Director at Neuberg Life Sciences Private Limited.

The current boards of Sowjanya Reddy Evuri's companies include Venkata Satyanarayana Reddy Chintakuntla (Neuberg Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available